# Molecular Surveillance of Artemisinin Resistance Malaria in Myanmar

> **NCT02792816** · — · COMPLETED · sponsor: **Department of Medical Research, Lower Myanmar** · enrollment: 550 (actual)

## Conditions studied

- Drug Resistance
- Plasmodium Falciparum Malaria

## Interventions

- **DRUG:** First line antimalarial in Myanmar (artemether-lumefrantrine, dihydroartemisinin-piperaquine, and artesunate-mefloquine)

## Key facts

- **NCT ID:** NCT02792816
- **Lead sponsor:** Department of Medical Research, Lower Myanmar
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2013-12
- **Final completion:** 2016-05
- **Target enrollment:** 550 (ACTUAL)
- **Last updated:** 2016-06-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02792816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02792816, "Molecular Surveillance of Artemisinin Resistance Malaria in Myanmar". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02792816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*